// App-Quantinova.ai

P34.04 : Chemo-Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) – Real World Data from a Tertiary Oncology Centre

Researchers

Presenter

  • S. Dulloo

Principal Investigators

  • S. Sharma

  • S. Ahmed

Medical Centers

  • Department of Oncology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester/GB

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved